We Partner with Health Plans and Care Groups to ensure High-risk Individuals have the best medication  care. 

We do this to support providers in caring for their most at-risk patient populations.

GoldenScripts’s platform helps individuals, family members, and high-risk patients with complex medication schedules by coordinating prescription care, reviewing medication adherence, and communicating risks with their primary care physicians.

Who We Partner With

  • Complex medication regimens challenge traditional insurance models. This creates unexpected costs and gaps in patient care. Our approach transforms medication management, for high-risk patients, by providing detailed tracking and proactive intervention.

    -> We help health plans move beyond claims management to support better patient health journeys.

  • Coordinating pharmacy care across multiple providers requires more than traditional oversight. Our end-to-end medication management platform creates a comprehensive view of patient prescriptions, highlighting potential interactions and adherence challenges. 

    ->By focusing on coordinated clinical pharmacy care for Medicare patients we help HMOs avoid unnecessary medication costs and patient health risks.

  • Physician care groups need comprehensive medication insights to deliver exceptional patient care. Our solution acts as an extension of their clinical team, providing real-time prescription tracking and personalized intervention strategies. 

    ->By focusing on high-risk patients, we empower physician groups to deliver more proactive and precise healthcare.

Give your patients the most advanced, comprehensive medication management on the market.

We provide a coordinated care team to work with your providers.

Value Based Care That Really Works

Targeting High-Risk, High-Cost Populations ->
We focus on hyper-polypharmacy members who drive disproportionate healthcare costs

Seamless Integration ->
Designed to complement PCP workflows and existing care management initiatives

Performance-Based Model ->
Fees are at risk, tied to measurable savings and clinical improvements